Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/03/21
End: 02/29/24
Due: 02/28/25
Phase: N/A
Priority: Normal
Start: 12/23/21
End: 12/15/25
Due: 12/15/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors | NCT04761601 | 1200 Pharma, LLC | user2@example.com | None | 2021-03-03 | 2024-02-29 | 2025-02-28 | - | - | 2025-07-14 |
| First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors | NCT05103046 | 1200 Pharma, LLC | user2@example.com | None | 2021-12-23 | 2025-12-15 | 2026-12-15 | - | - | 2025-07-14 |